Skip to main content
Clinical Trials/NCT02703142
NCT02703142
Completed
Not Applicable

Endoscopic Evaluation for the Postoperative Condition After Esophagectomy and Reconstruction

Nagasaki University1 site in 1 country10 target enrollmentOctober 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal Neoplasms
Sponsor
Nagasaki University
Enrollment
10
Locations
1
Primary Endpoint
Number of participants with endoscopy-related adverse events as assessed by Clavien-Dindo Classification
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Detailed Description

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. However the evaluation and prevention before developing gastric conduit ischemia have been established. The investigators have built a hypothesis that the evaluation for gastric mucosal ischemia in early phase after esophagectomy predict the complication of gastric conduit. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Registry
clinicaltrials.gov
Start Date
October 2015
End Date
October 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kobayashi Shinichiro

Assistant professor

Nagasaki University

Eligibility Criteria

Inclusion Criteria

  • Malignant or end-stage benign esophageal disease.
  • Esophagectomy with reconstruction by a gastric pull-up.

Exclusion Criteria

  • Severe heart failure and pulmonary dysfunction
  • Severe renal and liver dysfunction
  • Allergenic history
  • Pregnancy

Outcomes

Primary Outcomes

Number of participants with endoscopy-related adverse events as assessed by Clavien-Dindo Classification

Time Frame: From 1 to 29 days after esophagectomy

Number of participants with the classification of gastric conduit ischemia by endoscopic findings

Time Frame: From 1 to 15 days after esophagectomy

Number of participants with the major complications of gastric conduit (strictures, leakage, necrosis)

Time Frame: From 1 to 29 days after esophagectomy

Secondary Outcomes

  • Biological examination of the mucosal biopsy of gastric conduit as assessed by the scoring system for immunohistochemical staining(From 1 to 29 days after esophagectomy)
  • Biological examination of the mucosal biopsy of gastric conduit as assessed by the ischemia related RNA copy number(From 1 to 29 days after esophagectomy)
  • Biological examination of gastric conduit as assessed by the Mitochondrial DNA copy number(From 1 to 29 days after esophagectomy)

Study Sites (1)

Loading locations...

Similar Trials